Company CVAbout Tatva Chintan Pharma Chem Ltd 
Tatva Chintan Pharma Chem Ltd
Small Cap
Chemicals
Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996. The status of the Company converted from Private Limited into a Public Limited Company effective from 27 January 2021 and the name of Company also changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'. The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani.
Company Coordinates
No Company Details Available
Capital StructureCapital Structure
Present Equity Capital
INR 23.39 Cr
Number of Shares
2.34 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
29-Aug-2023
2.34
23.39
1226993
10
Qualified Institutional Placement
27-Jul-2021
2.22
22.17
2077562
10
Public Issue
03-Mar-2021
2.01
20.09
12052500
10
Bonus Issue
31-Mar-2015
80.35
8.04
3675000
10
Preferential Allotment
31-Mar-2014
43.6
4.36
360000
10
Preferential Allotment
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 2 Schemes (5.34%)
FIIs
Held by 15 FIIs (3.3%)
Promoter with highest holding
Shekhar Rasiklal Somani (23.07%)
Highest Public shareholder
Nippon Life India Trustee Ltd-a/c Nippon India Elss Tax Saver Fund (3.31%)
Individual Investors Holdings
16.92%
Board of Directors
Management
Designation
Remuneration
Chintan Nitinkumar Shah
Chairman / Executive Director
1.65 cr
Ajaykumar Mansukhlal Patel
WTD & Executive Director
1.65 cr
Shekhar Rasiklal Somani
WTD & Executive Director
1.65 cr
Subhash Patel
Independent Non Exe. Director
2.5 lacs
Avani Rajesh Umatt
Independent Non Exe. Director
1.8 lacs
Manher Chinmanlal Desai
Independent Non Exe. Director
2.3 lacs
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
86 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
Chemicals
INR 1,576 Cr (Small Cap)
107.00
41
0.31%
0.00
2.39%
2.07
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
